BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8004232)

  • 1. Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations.
    Napoli KL; Kahan BD
    J Chromatogr B Biomed Appl; 1994 Mar; 654(1):111-20. PubMed ID: 8004232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of rapamycin in whole blood by HPLC.
    Svensson JO; Brattström C; Säwe J
    Ther Drug Monit; 1997 Feb; 19(1):112-6. PubMed ID: 9029760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standards: application to sirolimus (rapamycin) determination.
    Ferron GM; Conway WD; Jusko WJ
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):243-51. PubMed ID: 9448082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection.
    Napoli KL; Kahan BD
    Clin Chem; 1996 Dec; 42(12):1943-8. PubMed ID: 8969630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry.
    Streit F; Christians U; Schiebel HM; Napoli KL; Ernst L; Linck A; Kahan BD; Sewing KF
    Clin Chem; 1996 Sep; 42(9):1417-25. PubMed ID: 8787698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatography.
    Maleki S; Graves S; Becker S; Horwatt R; Hicks D; Stroshane RM; Kincaid H
    Clin Ther; 2000; 22 Suppl B():B25-37. PubMed ID: 10823371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioreceptor assay for sirolimus.
    Goodyear N; Napoli KL; Murthy JN; Kahan BD; Soldin SJ
    Clin Biochem; 1996 Oct; 29(5):457-60. PubMed ID: 8884067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection.
    Cattaneo D; Perico N; Gaspari F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jul; 774(2):187-94. PubMed ID: 12076688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatographic method for the determination of sirolimus in blood using electrochemical detection.
    Mochizuki N; Suka E; Matsumoto K; Akimoto O; Ohno K; Shimamura T; Furukawa H; Todo S; Kishino S
    Biomed Chromatogr; 2009 Mar; 23(3):267-72. PubMed ID: 18814192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography.
    Yatscoff RW; Faraci C; Bolingbroke P
    Ther Drug Monit; 1992 Apr; 14(2):138-41. PubMed ID: 1585399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedure for determination of immunosuppressive drugs in whole blood with liquid chromatography-isotope dilution mass spectrometry.
    Molnár PM; Dux L; Reinauer H; Kress M; Akerboom T; Szederkényi E; Kaiser P
    Clin Lab; 2011; 57(11-12):983-92. PubMed ID: 22239031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
    Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
    Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of sirolimus in kidney transplant patients.
    Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of rapamycin.
    Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cyclosporin A in human and mouse plasma by reversed-phase high-performance liquid chromatography.
    Bardelmeijer HA; Ouwehand M; Beijnen JH; Schellens JH; van Tellingen O
    J Chromatogr B Biomed Sci Appl; 2001 Nov; 763(1-2):201-6. PubMed ID: 11710579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
    Yatscoff RW; LeGatt DF; Kneteman NM
    Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
    Li JL; Wang XD; Wang CX; Fu Q; Liu LS; Huang M; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):111-8. PubMed ID: 18417431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatography of rapamycin.
    Napoli KL; Kahan BD
    Clin Chem; 1991 Feb; 37(2):294-5. PubMed ID: 1993346
    [No Abstract]   [Full Text] [Related]  

  • 19. High-throughput semi-automated 96-well liquid/liquid extraction and liquid chromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood.
    Brignol N; McMahon LM; Luo S; Tse FL
    Rapid Commun Mass Spectrom; 2001; 15(12):898-907. PubMed ID: 11400194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific method for the measurement of cyclosporin A in human whole blood by liquid chromatography-tandem mass spectrometry.
    Simpson J; Zhang Q; Ozaeta P; Aboleneen H
    Ther Drug Monit; 1998 Jun; 20(3):294-300. PubMed ID: 9631926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.